{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:27:06Z","timestamp":1794565626188,"version":"4.9.1"},"reference-count":350,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008758","name":"State Council of Science and Technology Uttar Pradesh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008758","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bbcan.2026.189647","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T20:25:38Z","timestamp":1782851138000},"page":"189647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting transcriptional and post-transcriptional pathways in head and neck cancer"],"prefix":"10.1016","volume":"1881","author":[{"given":"Prabhat","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archita","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishabh","family":"Lakhera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayant","family":"Maini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhudev C.","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb0005","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s44276-024-00089-z","article-title":"Head and neck cancer incidence is rising but the sociodemographic profile is unchanging: a population epidemiological study (2001\u20132020)","volume":"2","author":"Smith","year":"2024","journal-title":"BJC Reports"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189647_bb0010","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189647_bb0015","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"9625","key":"10.1016\/j.bbcan.2026.189647_bb0020","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(08)60728-X","article-title":"Head and neck cancer","volume":"371","author":"Argiris","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.bbcan.2026.189647_bb0025","article-title":"Epidemiology and survival analysis of head and neck cancer: results from comprehensive care center in North India","volume":"6","author":"Badola","year":"2023","journal-title":"Oral Oncol. Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb0030","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4103\/2347-8128.182856","article-title":"Molecular biology of head and neck cancers","volume":"4","author":"Philip","year":"2016","journal-title":"J. Head Neck Phys. Surg."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189647_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.702","article-title":"Head and neck cancer: pathogenesis and targeted therapy","volume":"5","author":"Liu","year":"2024","journal-title":"MedComm"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189647_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100309","article-title":"Pan-Asian adaptation of the EHNS\u2013ESMO\u2013ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck","volume":"6","author":"Keam","year":"2021","journal-title":"ESMO Open"},{"key":"10.1016\/j.bbcan.2026.189647_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1665019","article-title":"Global burden of head and neck cancer: Epidemiological transitions, inequities, and projections to 2050","volume":"15","author":"Sun","year":"2025","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189647_bb0050","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1002\/ijc.28112","article-title":"Head and neck cancer: from anatomy to biology","volume":"133","author":"Bose","year":"2013","journal-title":"Int. J. Cancer"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189647_bb0055","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.bjps.2004.06.010","article-title":"Molecular introduction to head and neck cancer (HNSCC) carcinogenesis","volume":"57","author":"Chin","year":"2004","journal-title":"Br. J. Plast. Surg."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb0060","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","article-title":"Head and neck squamous cell carcinoma","volume":"6","author":"Johnson","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189647_bb0065","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1200\/JCO.2012.43.6097","article-title":"Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer","volume":"31","author":"Forastiere","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb0070","doi-asserted-by":"crossref","first-page":"25327","DOI":"10.1038\/s41598-024-75861-9","article-title":"HNCDrugResDb: a platform for deciphering drug resistance in head and neck cancers","volume":"14","author":"Palollathil","year":"2024","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189647_bb0075","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s12094-020-02533-1","article-title":"SEOM clinical guidelines for the treatment of head and neck cancer (2020)","volume":"23","author":"Mesia","year":"2021","journal-title":"Clin. Transl. Oncol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189647_bb0080","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/ijc.11698","article-title":"Head and neck tumor sites differ in prevalence and spectrum of p53 alterations but these have limited prognostic value","volume":"111","author":"Bosch","year":"2004","journal-title":"Int. J. Cancer"},{"issue":"14","key":"10.1016\/j.bbcan.2026.189647_bb0085","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1200\/JCO.2005.05.2308","article-title":"Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world","volume":"24","author":"Kamangar","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"18","key":"10.1016\/j.bbcan.2026.189647_bb0090","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1002\/cncr.32179","article-title":"A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer","volume":"125","author":"Patil","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2026.189647_bb0095","doi-asserted-by":"crossref","first-page":"16811","DOI":"10.1038\/srep16811","article-title":"Selective participation of c-Jun with Fra-2\/c-Fos promotes aggressive tumor phenotypes and poor prognosis in tongue cancer","volume":"5","author":"Gupta","year":"2015","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189647_bb0100","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1002\/ijc.22262","article-title":"Differential expression and activation of NF-kappaB family proteins during oral carcinogenesis: role of high risk human papillomavirus infection","volume":"119","author":"Mishra","year":"2006","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189647_bb0105","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1158\/1055-9965.EPI-08-0347","article-title":"Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the international head and neck cancer epidemiology consortium","volume":"18","author":"Hashibe","year":"2009","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"68","key":"10.1016\/j.bbcan.2026.189647_bb0110","doi-asserted-by":"crossref","first-page":"33011","DOI":"10.18632\/oncotarget.26041","article-title":"Constitutive activation and overexpression of NF-kappaB\/c-Rel in conjunction with p50 contribute to aggressive tongue tumorigenesis","volume":"9","author":"Gupta","year":"2018","journal-title":"Oncotarget"},{"issue":"20","key":"10.1016\/j.bbcan.2026.189647_bb0115","doi-asserted-by":"crossref","first-page":"5206","DOI":"10.3390\/cancers13205206","article-title":"The key differences between human papillomavirus-positive and-negative head and neck cancers: biological and clinical implications","volume":"13","author":"Powell","year":"2021","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189647_bb0120","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.currproblcancer.2018.03.003","article-title":"HPV: molecular pathways and targets","volume":"42","author":"Gupta","year":"2018","journal-title":"Curr. Probl. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb0125","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1186\/s12879-024-09357-2","article-title":"Prevalence of human papillomavirus in head and neck cancer patients in India: a systematic review and meta-analysis","volume":"24","author":"Satapathy","year":"2024","journal-title":"BMC Infect. Dis."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189647_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29746","article-title":"Advances in human papillomavirus detection and molecular understanding in head and neck cancers: implications for clinical management","volume":"96","author":"Tran","year":"2024","journal-title":"J. Med. Virol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb0135","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189647_bb0140","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s41415-022-5166-x","article-title":"Reviewing the epidemiology of head and neck cancer: definitions, trends and risk factors","volume":"233","author":"Gormley","year":"2022","journal-title":"Br. Dent. J."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189647_bb0145","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3390\/dj13120609","article-title":"The role of inflammasomes in chronic oral inflammatory disease and oral cancer: a narrative review","volume":"13","author":"Al-Natour","year":"2025","journal-title":"Dentistry J."},{"key":"10.1016\/j.bbcan.2026.189647_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2019.104453","article-title":"Potential role of microbiome in oncogenesis, outcome prediction and therapeutic targeting for head and neck cancer","volume":"99","author":"Orlandi","year":"2019","journal-title":"Oral Oncol."},{"key":"10.1016\/j.bbcan.2026.189647_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1198269","article-title":"The emerging role of oral microbiota in oral cancer initiation, progression and stemness","volume":"14","author":"Saikia","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb0160","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"20","key":"10.1016\/j.bbcan.2026.189647_bb0165","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.3390\/cancers16203488","article-title":"Review of current and future medical treatments in head and neck squamous cell carcinoma","volume":"16","author":"Lee","year":"2024","journal-title":"Cancers"},{"issue":"19","key":"10.1016\/j.bbcan.2026.189647_bb0170","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.3390\/cancers13194912","article-title":"An updated review on head and neck cancer treatment with radiation therapy","volume":"13","author":"Anderson","year":"2021","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189647_bb0175","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.oraloncology.2013.05.010","article-title":"Consensus recommendations for management of head and neck cancer in Asian countries: a review of international guidelines","volume":"49","author":"D\u2019cruz","year":"2013","journal-title":"Oral Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb0180","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41392-022-01297-0","article-title":"Targeted therapy for head and neck cancer: signaling pathways and clinical studies","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189647_bb0185","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.trecan.2018.03.006","article-title":"New therapies in head and neck cancer","volume":"4","author":"Santuray","year":"2018","journal-title":"Trends Cancer"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189647_bb0190","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/annonc\/mdy040","article-title":"Phase II trial of combination treatment with paclitaxel, carboplatin and cetuximab (PCE) as first-line treatment in patients with recurrent and\/or metastatic squamous cell carcinoma of the head and neck (CSPOR-HN02)","volume":"29","author":"Tahara","year":"2018","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189647_bb0195","doi-asserted-by":"crossref","first-page":"388","DOI":"10.5306\/wjco.v13.i5.388","article-title":"Immune checkpoint inhibitors in head and neck squamous cell carcinoma: a systematic review of phase-3 clinical trials","volume":"13","author":"Poulose","year":"2022","journal-title":"World J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2026.189647_bb0200","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nature14129","article-title":"Comprehensive genomic characterization of head and neck squamous cell carcinomas","volume":"517","author":"N. The Cancer Genome Atlas","year":"2015","journal-title":"Nature"},{"issue":"5-6","key":"10.1016\/j.bbcan.2026.189647_bb0205","doi-asserted-by":"crossref","first-page":"182","DOI":"10.18632\/genesandcancer.110","article-title":"Genetic determinants in head and neck squamous cell carcinoma and their influence on global personalized medicine","volume":"7","author":"Michmerhuizen","year":"2016","journal-title":"Genes Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb0210","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.gendis.2019.01.003","article-title":"Emerging roles of lncRNAs in the post-transcriptional regulation in cancer","volume":"6","author":"He","year":"2019","journal-title":"Genes Diseas"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb0215","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41392-023-01651-w","article-title":"Transcriptional co-activators: emerging roles in signaling pathways and potential therapeutic targets for diseases","volume":"8","author":"Talukdar","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb0220","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41598-025-29955-7","article-title":"Research on the resilience of ecological networks from the perspective of ecological security pattern: a case study of Wuhan metropolitan area","volume":"16","author":"Zhao","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2026.189647_bb0225","series-title":"Transcription Factors: A Potential Therapeutic Target in Head and Neck Squamous Cell Carcinoma","first-page":"57","author":"Pazhani","year":"2023"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb0230","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41392-023-01589-z","article-title":"Recent advances in targeting the \u201cundruggable\u201d proteins: from drug discovery to clinical trials","volume":"8","author":"Xie","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189647_bb0235","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cell.2018.03.035","article-title":"Oncogenic signaling pathways in the cancer genome atlas","volume":"173","author":"Sanchez-Vega","year":"2018","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189647_bb0240","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/gb-2009-10-7-311","article-title":"Defining and targeting transcription factors in cancer","volume":"10","author":"Redmond","year":"2009","journal-title":"Genome Biol."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189647_bb0245","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/01.cco.0000432528.88101.1a","article-title":"Targeting transcription factors: promising new strategies for cancer therapy","volume":"25","author":"Yeh","year":"2013","journal-title":"Curr. Opin. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb0250","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc2982","article-title":"The molecular biology of head and neck cancer","volume":"11","author":"Leemans","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189647_bb0255","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrc.2018.11","article-title":"The molecular landscape of head and neck cancer","volume":"18","author":"Leemans","year":"2018","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189647_bb0260","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41419-019-1769-9","article-title":"Clinical update on head and neck cancer: molecular biology and ongoing challenges","volume":"10","author":"Alsahafi","year":"2019","journal-title":"Cell Death Dis."},{"issue":"36","key":"10.1016\/j.bbcan.2026.189647_bb0265","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1200\/JCO.2005.04.6136","article-title":"High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma","volume":"24","author":"Licitra","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189647_bb0270","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/sj.ejhg.5201845","article-title":"The clinical relevance of microsatellite alterations in head and neck squamous cell carcinoma: a critical review","volume":"15","author":"De Schutter","year":"2007","journal-title":"Eur. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189647_bb0275","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3346\/jkms.2004.19.3.345","article-title":"Loss of heterozygosity on chromosomes 3p, 8p, 9p and 17p in the progression of squamous cell carcinoma of the larynx","volume":"19","author":"Yoo","year":"2004","journal-title":"J. Korean Med. Sci."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189647_bb0280","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3390\/biom14080925","article-title":"The next chapter in cancer diagnostics: advances in HPV-positive head and neck cancer","volume":"14","author":"Krsek","year":"2024","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189647_bb0285","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/ijc.24807","article-title":"Transactivation and expression patterns of Jun and Fos\/AP-1 super-family proteins in human oral cancer","volume":"126","author":"Mishra","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189647_bb0290","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1200\/JCO.2009.25.3641","article-title":"The PI3K pathway as drug target in human cancer","volume":"28","author":"Courtney","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"35","key":"10.1016\/j.bbcan.2026.189647_bb0295","doi-asserted-by":"crossref","first-page":"32124","DOI":"10.1074\/jbc.M203298200","article-title":"The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells","volume":"277","author":"Guha","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189647_bb0300","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.4049\/jimmunol.180.6.4218","article-title":"Genetic analysis of the role of the PI3K-Akt pathway in lipopolysaccharide-induced cytokine and tissue factor gene expression in monocytes\/macrophages","volume":"180","author":"Luyendyk","year":"2008","journal-title":"J. Immunol."},{"issue":"17","key":"10.1016\/j.bbcan.2026.189647_bb0305","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1242\/dev.063610","article-title":"Notch signaling: simplicity in design, versatility in function","volume":"138","author":"Andersson","year":"2011","journal-title":"Development"},{"issue":"7511","key":"10.1016\/j.bbcan.2026.189647_bb0310","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nature13393","article-title":"Targeting transcription regulation in cancer with a covalent CDK7 inhibitor","volume":"511","author":"Kwiatkowski","year":"2014","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189647_bb0315","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41389-018-0034-x","article-title":"Double agents: genes with both oncogenic and tumor-suppressor functions","volume":"7","author":"Shen","year":"2018","journal-title":"Oncogenesis"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189647_bb0320","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cell.2016.12.013","article-title":"Transcriptional addiction in cancer","volume":"168","author":"Bradner","year":"2017","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189647_bb0325","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nrc1209","article-title":"AP-1: a double-edged sword in tumorigenesis","volume":"3","author":"Eferl","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"21","key":"10.1016\/j.bbcan.2026.189647_bb0330","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.4161\/cc.6.21.4850","article-title":"Deciphering AP-1 function in tumorigenesis: fra-ternizing on target promoters","volume":"6","author":"Verde","year":"2007","journal-title":"Cell Cycle"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189647_bb0335","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29080","article-title":"Artificial intelligence for HPV status prediction based on disease-specific images in head and neck cancer: a systematic review and meta-analysis","volume":"95","author":"Song","year":"2023","journal-title":"J. Med. Virol."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189647_bb0340","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/ijc.20668","article-title":"Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin","volume":"113","author":"Prusty","year":"2005","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb0345","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/1471-2407-9-329","article-title":"Transcription factor AP-1 in esophageal squamous cell carcinoma: alterations in activity and expression during human Papillomavirus infection","volume":"9","author":"Hussain","year":"2009","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189647_bb0350","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/bjc.2013.774","article-title":"c-FOS suppresses ovarian cancer progression by changing adhesion","volume":"110","author":"Oliveira-Ferrer","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb0355","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1038\/s41598-017-05162-x","article-title":"Cervical cancer stem cells manifest radioresistance: association with upregulated AP-1 activity","volume":"7","author":"Tyagi","year":"2017","journal-title":"Sci. Rep."},{"issue":"23","key":"10.1016\/j.bbcan.2026.189647_bb0360","doi-asserted-by":"crossref","first-page":"34371","DOI":"10.18632\/oncotarget.9110","article-title":"FRA1 promotes squamous cell carcinoma growth and metastasis through distinct AKT and c-Jun dependent mechanisms","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189647_bb0365","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1158\/1078-0432.CCR-16-2811","article-title":"Involvement of c-Fos in the promotion of cancer stem-like cell properties in head and neck squamous cell carcinoma","volume":"23","author":"Muhammad","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189647_bb0370","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.stem.2017.02.003","article-title":"Targeting BMI1(+) cancer stem cells overcomes chemoresistance and inhibits metastases in squamous cell carcinoma","volume":"20","author":"Chen","year":"2017","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb0375","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/jvi.71.1.362-370.1997","article-title":"Antioxidant-induced changes of the AP-1 transcription complex are paralleled by a selective suppression of human papillomavirus transcription","volume":"71","author":"Rosl","year":"1997","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189647_bb0380","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1158\/1535-7163.MCT-07-2046","article-title":"Differential bortezomib sensitivity in head and neck cancer lines corresponds to proteasome, nuclear factor-kappaB and activator protein-1 related mechanisms","volume":"7","author":"Chen","year":"2008","journal-title":"Mol. Cancer Ther."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189647_bb0385","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/j.ijrobp.2024.01.072","article-title":"Clinical validation of nuclear factor Kappa B (p65) among head and neck cancer patients at one institution","volume":"118","author":"Saahene","year":"2024","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"45","key":"10.1016\/j.bbcan.2026.189647_bb0390","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1038\/onc.2008.271","article-title":"The tumor microenvironment and its role in promoting tumor growth","volume":"27","author":"Whiteside","year":"2008","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189647_bb0395","doi-asserted-by":"crossref","first-page":"350","DOI":"10.26574\/maedica.2024.19.2.350","article-title":"C-Jun transcription factor oncogenic activation in oral carcinoma","volume":"19","author":"Mastronikolis","year":"2024","journal-title":"Maedica"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189647_bb0400","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/mc.20775","article-title":"Tobacco carcinogen mediated up-regulation of AP-1 dependent pro-angiogenic cytokines in head and neck carcinogenesis","volume":"50","author":"Swenson","year":"2011","journal-title":"Mol. Carcinog."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189647_bb0405","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1002\/ijc.29558","article-title":"NF-\u03baB and stat3 transcription factor signatures differentiate HPV-positive and HPV-negative head and neck squamous cell carcinoma","volume":"137","author":"Gaykalova","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189647_bb0410","doi-asserted-by":"crossref","first-page":"707","DOI":"10.18632\/oncotarget.28232","article-title":"NF-\u03baB over-activation portends improved outcomes in HPV-associated head and neck cancer","volume":"13","author":"Schrank","year":"2022","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.bbcan.2026.189647_bb0415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205518","article-title":"The role of NF-kappaB and miRNA in oral cancer and cancer stem cells with or without HPV16 infection","volume":"13","author":"Bano","year":"2018","journal-title":"PLoS One"},{"issue":"40","key":"10.1016\/j.bbcan.2026.189647_bb0420","doi-asserted-by":"crossref","first-page":"11283","DOI":"10.1073\/pnas.1607606113","article-title":"Whole-exome sequencing identifies multiple loss-of-function mutations of NF-\u03baB pathway regulators in nasopharyngeal carcinoma","volume":"113","author":"Zheng","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189647_bb0425","doi-asserted-by":"crossref","first-page":"977","DOI":"10.3390\/v12090977","article-title":"Manipulation of JAK\/STAT signalling by high-risk HPVs: potential therapeutic targets for HPV-associated malignancies","volume":"12","author":"Morgan","year":"2020","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189647_bb0430","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3892\/wasj.2025.330","article-title":"NF-\u03baB (p65) protein expression in head and neck tumors and its association with clinicopathological parameters","volume":"7","author":"Barnes","year":"2025","journal-title":"World Acad. Sci. J."},{"key":"10.1016\/j.bbcan.2026.189647_bb0435","article-title":"Expression analysis of nuclear factor kappa B (NF-\u03baB) in oral squamous cell carcinoma","volume":"10","author":"Arora","year":"2024","journal-title":"Oral Oncol. Rep."},{"issue":"4653","key":"10.1016\/j.bbcan.2026.189647_bb0440","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1126\/science.6719137","article-title":"Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage","volume":"224","author":"Brodeur","year":"1984","journal-title":"Science"},{"issue":"7213","key":"10.1016\/j.bbcan.2026.189647_bb0445","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nature07260","article-title":"Modelling Myc inhibition as a cancer therapy","volume":"455","author":"Soucek","year":"2008","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb0450","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","article-title":"MYC on the path to cancer","volume":"149","author":"Dang","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189647_bb0455","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41392-018-0008-7","article-title":"Targeting oncogenic Myc as a strategy for cancer treatment","volume":"3","author":"Chen","year":"2018","journal-title":"Signal Transduct. Target. Ther."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189647_bb0460","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cdp.2004.02.003","article-title":"Clinical significance of c-myc and p53 expression in head and neck squamous cell carcinomas","volume":"28","author":"Waitzberg","year":"2004","journal-title":"Cancer Detect. Prev."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189647_bb0465","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/jop.12579","article-title":"Patients with high c-MYC-expressing squamous cell carcinomas of the tongue show better survival than those with low- and medium-expressing tumours","volume":"46","author":"Strindlund","year":"2017","journal-title":"J. Oral Pathol. Med."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189647_bb0470","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/s41419-018-0887-0","article-title":"PAK2\u2013c-Myc\u2013PKM2 axis plays an essential role in head and neck oncogenesis via regulating Warburg effect","volume":"9","author":"Gupta","year":"2018","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb0475","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2130583","article-title":"Therapeutic targeting of MYC in head and neck squamous cell carcinoma","volume":"11","author":"Liu","year":"2022","journal-title":"Oncoimmunology"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189647_bb0480","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41419-023-06248-3","article-title":"c-MYC-dependent transcriptional inhibition of autophagy is implicated in cisplatin sensitivity in HPV-positive head and neck cancer","volume":"14","author":"Medda","year":"2023","journal-title":"Cell Death Dis."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189647_bb0485","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.neo.2021.10.003","article-title":"STAT3 as a mediator of oncogenic cellular metabolism: pathogenic and therapeutic implications","volume":"23","author":"To\u0161i\u0107","year":"2021","journal-title":"Neoplasia"},{"key":"10.1016\/j.bbcan.2026.189647_bb0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13578-020-00524-x","article-title":"STAT3 plays an important role in DNA replication by turning on WDHD1","volume":"11","author":"Zhou","year":"2021","journal-title":"Cell Biosci."},{"key":"10.1016\/j.bbcan.2026.189647_bb0495","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.oraloncology.2015.11.022","article-title":"The STAT3 pathway as a therapeutic target in head and neck cancer: Barriers and innovations","volume":"56","author":"Geiger","year":"2016","journal-title":"Oral Oncol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189647_bb0500","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1517\/14712598.6.3.231","article-title":"STAT3 as a therapeutic target in head and neck cancer","volume":"6","author":"Leeman","year":"2006","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189647_bb0505","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1158\/2159-8290.CD-12-0191","article-title":"First-in-human trial of a STAT3 decoy oligonucleotide in head and neck tumors: implications for cancer therapy","volume":"2","author":"Sen","year":"2012","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb0510","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41420-024-01833-7","article-title":"IL-8 activates fibroblasts to promote the invasion of HNSCC cells via STAT3-MMP1","volume":"10","author":"Chen","year":"2024","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb0515","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41368-024-00279-y","article-title":"WNT7A promotes tumorigenesis of head and neck squamous cell carcinoma via activating FZD7\/JAK1\/STAT3 signaling","volume":"16","author":"Huang","year":"2024","journal-title":"Int. J. Oral Sci."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189647_bb0520","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/jnci\/djz036","article-title":"STAT3 modulation of regulatory T cells in response to radiation therapy in head and neck cancer","volume":"111","author":"Oweida","year":"2019","journal-title":"J. Nation Cancer Inst."},{"issue":"45","key":"10.1016\/j.bbcan.2026.189647_bb0525","doi-asserted-by":"crossref","first-page":"5826","DOI":"10.1038\/onc.2016.124","article-title":"SUMOylation and SENP3 regulate STAT3 activation in head and neck cancer","volume":"35","author":"Zhou","year":"2016","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189647_bb0530","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.humpath.2010.11.010","article-title":"SOX2 amplification is a common event in squamous cell carcinomas of different organ sites","volume":"42","author":"Maier","year":"2011","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.bbcan.2026.189647_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113860","article-title":"SOX2 function in cancers: association with growth, invasion, stemness and therapy response","volume":"156","author":"Mirzaei","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189647_bb0540","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1038\/bjc.2014.528","article-title":"SOX2 regulates self-renewal and tumorigenicity of stem-like cells of head and neck squamous cell carcinoma","volume":"111","author":"Lee","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189647_bb0545","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3390\/cancers11030286","article-title":"The novel role of SOX2 as an early predictor of cancer risk in patients with laryngeal precancerous lesions","volume":"11","author":"Granda-D\u00edaz","year":"2019","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189647_bb0550","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.3390\/cancers12071794","article-title":"Prognostic significance of the pluripotency factors NANOG, SOX2, and OCT4 in head and neck squamous cell carcinomas","volume":"12","author":"Pedregal-Mallo","year":"2020","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189647_bb0555","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3390\/biology9110387","article-title":"Prognostic implication of SOX2 expression associated with p16 in oropharyngeal cancer: a study of consecutive tissue microarrays and TCGA","volume":"9","author":"Seok","year":"2020","journal-title":"Biology"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189647_bb0560","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3390\/cancers16020439","article-title":"The role of SOX2 and SOX9 in radioresistance and tumor recurrence","volume":"16","author":"Barbosa","year":"2024","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189647_bb0565","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.tcb.2006.12.001","article-title":"HMG chromosomal proteins in development and disease","volume":"17","author":"Hock","year":"2007","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bbcan.2026.189647_bb0570","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3389\/fmed.2015.00015","article-title":"High mobility group a proteins as tumor markers","volume":"2","author":"Pallante","year":"2015","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2022.113271","article-title":"HMGA2-Snai2 axis regulates tumorigenicity and stemness of head and neck squamous cell carcinoma","volume":"418","author":"Li","year":"2022","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbcan.2026.189647_bb0580","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-016-0777-0","article-title":"Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway","volume":"14","author":"Zhao","year":"2016","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189647_bb0585","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1158\/1055-9965.EPI-16-0492","article-title":"The stem cell factor HMGA2 is expressed in non-HPV\u2013associated head and neck squamous cell carcinoma and predicts patient survival of distinct subsites","volume":"26","author":"G\u00fcnther","year":"2017","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189647_bb0590","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/his.13456","article-title":"HMGA 2, but not HMGA 1, is overexpressed in human larynx carcinomas","volume":"72","author":"Palumbo","year":"2018","journal-title":"Histopathology"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189647_bb0595","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1111\/odi.14399","article-title":"hsa_circ_0000264 promotes tumor progression via the hsa-let-7b-5p\/HMGA2 axis in head and neck squamous cell carcinoma","volume":"29","author":"Xue","year":"2023","journal-title":"Oral Dis."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189647_bb0600","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.4161\/cc.8.9.8314","article-title":"The involvement of the transcription factor Yin Yang 1 in cancer development and progression","volume":"8","author":"Castellano","year":"2009","journal-title":"Cell Cycle"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189647_bb0605","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/sj.onc.1209080","article-title":"Transcription factor YY1: structure, function, and therapeutic implications in cancer biology","volume":"25","author":"Gordon","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189647_bb0610","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3389\/fonc.2019.01230","article-title":"The two sides of YY1 in cancer: a friend and a foe","volume":"9","author":"Sarvagalla","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2026.189647_bb0615","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.592164","article-title":"The why of YY1: mechanisms of transcriptional regulation by Yin Yang 1","volume":"8","author":"Verheul","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189647_bb0620","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00432-020-03482-6","article-title":"Transcription factors CP2 and YY1 as prognostic markers in head and neck squamous cell carcinoma: analysis of The Cancer Genome Atlas and a second independent cohort","volume":"147","author":"Schnoell","year":"2021","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"38","key":"10.1016\/j.bbcan.2026.189647_bb0625","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.18632\/oncotarget.26984","article-title":"Functional interplay between YY1 and CARM1 promotes oral carcinogenesis","volume":"10","author":"Behera","year":"2019","journal-title":"Oncotarget"},{"issue":"42","key":"10.1016\/j.bbcan.2026.189647_bb0630","doi-asserted-by":"crossref","first-page":"73029","DOI":"10.18632\/oncotarget.20373","article-title":"Expression of the long non-coding RNA HOTAIR as a prognostic factor in squamous cell carcinoma of the head and neck: a systematic review and meta-analysis","volume":"8","author":"Troiano","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb0635","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ajpath.2012.08.042","article-title":"Long intergenic noncoding RNA HOTAIR is overexpressed and regulates PTEN methylation in laryngeal squamous cell carcinoma","volume":"182","author":"Li","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbcan.2026.189647_bb0640","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.997633","article-title":"A review of current evidence about lncRNA MEG3: a tumor suppressor in multiple cancers","volume":"10","author":"Xu","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189647_bb0645","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/cam4.1073","article-title":"YY 1 directly suppresses MYCT 1 leading to laryngeal tumorigenesis and progress","volume":"6","author":"Qu","year":"2017","journal-title":"Cancer Med."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189647_bb0650","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/s41419-018-0774-8","article-title":"Knockdown of Yin Yang 1 enhances anticancer effects of cisplatin through protein phosphatase 2A-mediated T308 dephosphorylation of AKT","volume":"9","author":"Zhao","year":"2018","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189647_bb0655","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/odi.70147","article-title":"YY1 induced FOXD2-AS1 drives proliferation of oral squamous cell carcinoma through EZH2\/CDKN1A Axis","volume":"32","author":"Yu","year":"2025","journal-title":"Oral Dis"},{"key":"10.1016\/j.bbcan.2026.189647_bb0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcp.2020.101577","article-title":"YY1-mediated PTEN dephosphorylation antagonizes IR-induced DNA repair contributing to tongue squamous cell carcinoma radiosensitization","volume":"53","author":"Zhao","year":"2020","journal-title":"Mol. Cell. Probes"},{"issue":"5415","key":"10.1016\/j.bbcan.2026.189647_bb0665","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1126\/science.284.5415.770","article-title":"Notch signaling: cell fate control and signal integration in development","volume":"284","author":"Artavanis-Tsakonas","year":"1999","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189647_bb0670","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cell.2009.03.045","article-title":"The canonical Notch signaling pathway: unfolding the activation mechanism","volume":"137","author":"Kopan","year":"2009","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189647_bb0675","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1074-7613(03)00325-X","article-title":"Notch and the immune system","volume":"19","author":"Maillard","year":"2003","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189647_bb0680","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ccr.2014.02.018","article-title":"From fly wings to targeted cancer therapies: a centennial for notch signaling","volume":"25","author":"Ntziachristos","year":"2014","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189647_bb0685","first-page":"108","article-title":"Coactivation of NF-\u03baB and Notch signaling is sufficient to induce B-cell transformation and enables B-myeloid conversion","volume":"135","author":"Xiu","year":"2020","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189647_bb0690","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1177\/0022034518760297","article-title":"The NOTCH pathway in head and neck squamous cell carcinoma","volume":"97","author":"Fukusumi","year":"2018","journal-title":"J. Dent. Res."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189647_bb0695","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/labinvest.2015.163","article-title":"Notch1 signaling contributes to stemness in head and neck squamous cell carcinoma","volume":"96","author":"Lee","year":"2016","journal-title":"Lab. Investig."},{"issue":"6046","key":"10.1016\/j.bbcan.2026.189647_bb0700","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1126\/science.1206923","article-title":"Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1","volume":"333","author":"Agrawal","year":"2011","journal-title":"Science"},{"issue":"6046","key":"10.1016\/j.bbcan.2026.189647_bb0705","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1126\/science.1208130","article-title":"The mutational landscape of head and neck squamous cell carcinoma","volume":"333","author":"Stransky","year":"2011","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189647_bb0710","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/15384101.2017.1395534","article-title":"Notch1 regulates tongue cancer cells proliferation, apoptosis and invasion","volume":"17","author":"Gan","year":"2018","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbcan.2026.189647_bb0715","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2025.e42733","article-title":"The role of miR-16 and miR-34a family in the regulation of cancers: a review","volume":"11","author":"Sadeghi","year":"2025","journal-title":"Heliyon"},{"key":"10.1016\/j.bbcan.2026.189647_bb0720","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2021.153474","article-title":"NOTCH1 mutations as prognostic marker in oral squamous cell carcinoma","volume":"223","author":"Wu-Chou","year":"2021","journal-title":"Pathol. Res. Pract."},{"issue":"18","key":"10.1016\/j.bbcan.2026.189647_bb0725","doi-asserted-by":"crossref","first-page":"9167","DOI":"10.3390\/ijms26189167","article-title":"Immunohistochemical evaluation of NOTCH1 signaling pathway in oral squamous cell carcinoma: clinical and prognostic significance","volume":"26","author":"de Vicente","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"24","key":"10.1016\/j.bbcan.2026.189647_bb0730","doi-asserted-by":"crossref","first-page":"6308","DOI":"10.1158\/1078-0432.CCR-17-3535","article-title":"Loss of function of canonical Notch signaling drives head and neck carcinogenesis","volume":"24","author":"Nyman","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189647_bb0735","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3390\/ijms19030830","article-title":"High NOTCH1 mRNA expression is associated with better survival in HNSCC","volume":"19","author":"Wirth","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189647_bb0740","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1158\/1078-0432.CCR-12-2119","article-title":"Prolonged inhibition of glioblastoma xenograft initiation and clonogenic growth following in vivo Notch blockade","volume":"19","author":"Chu","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189647_bb0745","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.anl.2016.08.003","article-title":"Notch1 regulates invasion and metastasis of head and neck squamous cell carcinoma by inducing EMT through c-Myc","volume":"44","author":"Inamura","year":"2017","journal-title":"Auris Nasus Larynx"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189647_bb0750","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.oraloncology.2013.07.011","article-title":"Molecular mechanisms of HPV induced carcinogenesis in head and neck","volume":"50","author":"Rampias","year":"2014","journal-title":"Oral Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb0755","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev-pathol-052016-100127","article-title":"The varied roles of notch in cancer","volume":"12","author":"Aster","year":"2017","journal-title":"Ann. Rev. Pathol. Mechan. Disease"},{"issue":"31","key":"10.1016\/j.bbcan.2026.189647_bb0760","doi-asserted-by":"crossref","first-page":"50437","DOI":"10.18632\/oncotarget.10419","article-title":"Notch pathway activation is essential for maintenance of stem-like cells in early tongue cancer","volume":"7","author":"Upadhyay","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb0765","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.canlet.2013.01.054","article-title":"Notch signaling pathway targeted therapy suppresses tumor progression and metastatic spread in pancreatic cancer","volume":"335","author":"Yabuuchi","year":"2013","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb0770","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1186\/s12935-021-02396-8","article-title":"p53 signaling in cancer progression and therapy","volume":"21","author":"Marei","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"6046","key":"10.1016\/j.bbcan.2026.189647_bb0775","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1126\/science.1208130","article-title":"The mutational landscape of head and neck squamous cell carcinoma","volume":"333","author":"Stransky","year":"2011","journal-title":"Science"},{"issue":"02","key":"10.1016\/j.bbcan.2026.189647_bb0780","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.wjorl.2016.05.005","article-title":"Novel p53 therapies for head and neck cancer","volume":"2","author":"Castellanos","year":"2016","journal-title":"World J. Otorhinolaryngol. Head Neck Surg."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb0785","doi-asserted-by":"crossref","first-page":"20776","DOI":"10.1038\/s41598-022-25291-2","article-title":"Value of p53 sequencing in the prognostication of head and neck cancer: a systematic review and meta-analysis","volume":"12","author":"Basyuni","year":"2022","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189647_bb0790","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1158\/1078-0432.CCR-21-4316","article-title":"Association of T P53 and CDKN2A mutation profile with tumor mutation burden in head and neck cancer","volume":"28","author":"Deneka","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189647_bb0795","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.3390\/cancers15102722","article-title":"The role of the p16 and p53 tumor suppressor proteins and viral HPV16 E6 and E7 oncoproteins in the assessment of survival in patients with head and neck cancers associated with human papillomavirus infections","volume":"15","author":"Lifsics","year":"2023","journal-title":"Cancers"},{"issue":"6729","key":"10.1016\/j.bbcan.2026.189647_bb0800","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/19531","article-title":"p63 is a p53 homologue required for limb and epidermal morphogenesis","volume":"398","author":"Mills","year":"1999","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189647_bb0805","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1073\/pnas.061032098","article-title":"p63 identifies keratinocyte stem cells","volume":"98","author":"Pellegrini","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189647_bb0810","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.cell.2009.04.037","article-title":"Blinded by the light: the growing complexity of p53","volume":"137","author":"Vousden","year":"2009","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189647_bb0815","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1080\/07357900701509387","article-title":"Effect of p63 expression on survival in oral squamous cell carcinoma","volume":"25","author":"Muzio","year":"2007","journal-title":"Cancer Investig."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189647_bb0820","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1172\/JCI59889","article-title":"The molecular pathogenesis of head and neck squamous cell carcinoma","volume":"122","author":"Rothenberg","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb0825","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ccell.2016.12.001","article-title":"ACTL6A is co-amplified with p63 in squamous cell carcinoma to drive YAP activation, regenerative proliferation, and poor prognosis","volume":"31","author":"Saladi","year":"2017","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189647_bb0830","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1158\/1541-7786.MCR-18-1355","article-title":"Loss of TP63 promotes the metastasis of head and neck squamous cell carcinoma by activating MAPK and STAT3 signaling","volume":"17","author":"Lakshmanachetty","year":"2019","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189647_bb0835","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.879054","article-title":"p63 directs subtype-specific gene expression in HPV+ head and neck squamous cell carcinoma","volume":"12","author":"Glathar","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb0840","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00580-17","article-title":"Identification of head and neck cancer subtypes based on human papillomavirus presence and E2F-regulated gene expression","volume":"3","author":"Johnson","year":"2018","journal-title":"MSphere"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb0845","first-page":"38","article-title":"Roles of E2F family members in the diagnosis and prognosis of head and neck squamous cell carcinoma","volume":"16","author":"Li","year":"2023","journal-title":"BMC Med. Genet."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb0850","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12957-025-03808-z","article-title":"E2F expression profiling-based subtypes in head and neck squamous cell carcinoma: clinical relevance, prognostic implications, and personalized therapy","volume":"23","author":"Jiang","year":"2025","journal-title":"World J. Surg. Oncol."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189647_bb0855","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/embo-reports\/kve230","article-title":"Non-coding RNAs: the architects of eukaryotic complexity","volume":"2","author":"Mattick","year":"2001","journal-title":"EMBO Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb0860","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028213","article-title":"Evidence for transcript networks composed of chimeric RNAs in human cells","volume":"7","author":"Djebali","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2026.189647_bb0865","first-page":"086","article-title":"PIWI-interacting RNAs in oral cancer: paradigm shift in prognosis and diagnosis","volume":"11","author":"Gupta","year":"2019","journal-title":"J. Cancer Sci. Ther."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189647_bb0870","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.canep.2015.10.025","article-title":"Polymorphisms in lncRNA HOTAIR and susceptibility to breast cancer in a Chinese population","volume":"39","author":"Yan","year":"2015","journal-title":"Cancer Epidemiol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb0875","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.18632\/oncotarget.22608","article-title":"Current research on head and neck cancer-associated long noncoding RNAs","volume":"9","author":"Song","year":"2018","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb0880","doi-asserted-by":"crossref","first-page":"15972","DOI":"10.1038\/srep15972","article-title":"Long non coding RNA MALAT1 promotes tumor growth and metastasis by inducing epithelial-mesenchymal transition in oral squamous cell carcinoma","volume":"5","author":"Zhou","year":"2015","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189647_bb0885","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.3892\/or.2017.5445","article-title":"Long non-coding RNA MALAT1 interacts with miR-124 and modulates tongue cancer growth by targeting JAG1","volume":"37","author":"Zhang","year":"2017","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189647_bb0890","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3892\/ol.2021.12563","article-title":"The HOTAIR lncRNA: a remarkable oncogenic promoter in human cancer metastasis","volume":"21","author":"Chen","year":"2021","journal-title":"Oncol. Lett."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189647_bb0895","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/mc.23159","article-title":"LncRNA HOTAIR promotes the invasion and metastasis of oral squamous cell carcinoma through metastasis-associated gene 2","volume":"59","author":"Tao","year":"2020","journal-title":"Mol. Carcinog."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189647_bb0900","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.ejca.2004.11.023","article-title":"Human papillomavirus-16 associated squamous cell carcinoma of the head and neck (SCCHN): a natural disease model provides insights into viral carcinogenesis","volume":"41","author":"Ferris","year":"2005","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189647_bb0905","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2024.110170","article-title":"The LINC00319 binding to STAT3 promotes the cell proliferation, migration, invasion and EMT process in oral squamous cell carcinoma","volume":"761","author":"Jiang","year":"2024","journal-title":"Arch. Biochem. Biophys."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189647_bb0910","first-page":"211","article-title":"Long non-coding RNA taurine upregulated 1 regulates the progression of head and neck cancer","volume":"87","author":"Nioka","year":"2025","journal-title":"Nagoya J. Med. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb0915","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s10020-021-00312-4","article-title":"Role of long noncoding RNA taurine-upregulated gene 1 in cancers","volume":"27","author":"Da","year":"2021","journal-title":"Mol. Med."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189647_bb0920","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202051042","article-title":"Long non-coding RNA ELDR enhances oral cancer growth by promoting ILF3-cyclin E1 signaling, The","volume":"21","author":"Sur","year":"2020","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bbcan.2026.189647_bb0925","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-94-017-7417-8_4","article-title":"The piRNA pathway guards the germline genome against transposable elements","volume":"886","author":"Toth","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbcan.2026.189647_bb0930","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12943-016-0491-9","article-title":"Piwi-interacting RNAs in cancer: emerging functions and clinical utility","volume":"15","author":"Ng","year":"2016","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189647_bb0935","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s10120-015-0487-y","article-title":"An atlas of gastric PIWI-interacting RNA transcriptomes and their utility for identifying signatures of gastric cancer recurrence","volume":"19","author":"Martinez","year":"2015","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.bbcan.2026.189647_bb0940","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.oraloncology.2016.01.012","article-title":"HPV status is associated with altered PIWI-interacting RNA expression pattern in head and neck cancer","volume":"55","author":"Firmino","year":"2016","journal-title":"Oral Oncol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189647_bb0945","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.18632\/oncotarget.23464","article-title":"Computational methods reveal novel functionalities of PIWI-interacting RNAs in human papillomavirus-induced head and neck squamous cell carcinoma","volume":"9","author":"Krishnan","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189647_bb0950","doi-asserted-by":"crossref","first-page":"10615","DOI":"10.2147\/OTT.S233322","article-title":"Piwi-interacting RNA1037 enhances chemoresistance and motility in human oral squamous cell carcinoma cells","author":"Li","year":"2019","journal-title":"Onco. Targets Ther."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189647_bb0955","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1158\/1078-0432.CCR-13-2675","article-title":"Clusterin is a gene-specific target of microRNA-21 in head and neck squamous cell carcinoma","volume":"20","author":"Mydlarz","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189647_bb0960","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3390\/jpm11080821","article-title":"The prognostic role of Micro-RNAs in head and neck cancers: An umbrella review","volume":"11","author":"Mariani","year":"2021","journal-title":"J. Personal. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb0965","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","article-title":"Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets","volume":"120","author":"Lewis","year":"2005","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189647_bb0970","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1997","article-title":"MicroRNA signatures in human cancers","volume":"6","author":"Calin","year":"2006","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb0975","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cell.2005.06.036","article-title":"miRNAs, cancer, and stem cell division","volume":"122","author":"Croce","year":"2005","journal-title":"Cell"},{"issue":"24","key":"10.1016\/j.bbcan.2026.189647_bb0980","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1093\/hmg\/ddp446","article-title":"Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma","volume":"18","author":"Cervigne","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbcan.2026.189647_bb0985","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1174330","article-title":"Pharmacological impact of microRNAs in head and neck squamous cell carcinoma: prevailing insights on molecular pathways, diagnosis, and nanomedicine treatment","volume":"14","author":"Bhattacharjee","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189647_bb0990","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3390\/cancers14040895","article-title":"Tissue miRNA combinations for the differential diagnosis of adrenocortical carcinoma and adenoma established by artificial intelligence","volume":"14","author":"Turai","year":"2022","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189647_bb0995","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.oraloncology.2013.01.001","article-title":"Oncogenic microRNAs as biomarkers of oral tumorigenesis and minimal residual disease","volume":"49","author":"Santhi","year":"2013","journal-title":"Oral Oncol."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189647_bb1000","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1158\/1078-0432.CCR-08-3053","article-title":"MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor","volume":"15","author":"Li","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189647_bb1005","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1158\/1078-0432.CCR-07-0666","article-title":"Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue","volume":"14","author":"Wong","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189647_bb1010","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.376","article-title":"Tumor suppressor PDCD4 modulates miR-184-mediated direct suppression of C-MYC and BCL2 blocking cell growth and survival in nasopharyngeal carcinoma","volume":"4","author":"Zhen","year":"2013","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189647_bb1015","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1023\/A:1024039802134","article-title":"Comparison of gene expression between metastatic derivatives and their poorly metastatic parental cells implicates crucial tumor-environment interaction in metastasis of head and neck squamous cell carcinoma","volume":"20","author":"Chen","year":"2003","journal-title":"Clin. Exp. Metastasis"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189647_bb1020","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ccr.2011.10.014","article-title":"Targeting of the tumor suppressor GRHL3 by a miR-21-dependent proto-oncogenic network results in PTEN loss and tumorigenesis","volume":"20","author":"Darido","year":"2011","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189647_bb1025","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1007\/s11033-011-1350-9","article-title":"miR-21 inhibitor sensitizes human OSCC cells to cisplatin","volume":"39","author":"Wang","year":"2012","journal-title":"Mol. Biol. Rep."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189647_bb1030","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.oraloncology.2010.02.002","article-title":"MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines","volume":"46","author":"Yu","year":"2010","journal-title":"Oral Oncol."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189647_bb1035","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/gcc.20666","article-title":"Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy","volume":"48","author":"Henson","year":"2009","journal-title":"Genes Chromosom. Cancer"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189647_bb1040","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/onc.2013.13","article-title":"Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway","volume":"33","author":"Nakanishi","year":"2013","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189647_bb1045","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2353\/ajpath.2009.080731","article-title":"Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma","volume":"174","author":"Childs","year":"2009","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189647_bb1050","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1158\/1078-0432.CCR-09-2166","article-title":"Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas","volume":"16","author":"Hui","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189647_bb1055","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.ajpath.2011.12.004","article-title":"Low-level expression of miR-375 correlates with poor outcome and metastasis while altering the invasive properties of head and neck squamous cell carcinomas","volume":"180","author":"Harris","year":"2012","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189647_bb1060","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3390\/curroncol29020069","article-title":"Micro-RNAs, the cornerstones of the future of radiobiology in head and neck cancers?","volume":"29","author":"Mire\u0219tean","year":"2022","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.bbcan.2026.189647_bb1065","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.2147\/COPD.S266021","article-title":"The predictive value of microRNA-134 and microRNA-1233 for the early diagnosis of acute exacerbation of chronic obstructive pulmonary disease with acute pulmonary embolism","author":"Peng","year":"2020","journal-title":"Int. J. Chron. Obstruct Pulmon. Dis."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189647_bb1070","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.3390\/cancers13071742","article-title":"Roles of micrornas in regulating cancer stemness in head and neck cancers","volume":"13","author":"Fitriana","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2026.189647_bb1075","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101827","article-title":"Saliva as a potential non-invasive liquid biopsy for early and easy diagnosis\/prognosis of head and neck cancer","volume":"40","author":"Kumar","year":"2024","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bbcan.2026.189647_bb1080","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2019.104465","article-title":"miRNAs in liquid biopsy for oral squamous cell carcinoma diagnosis: systematic review and meta-analysis","volume":"99","author":"Rapado-Gonz\u00e1lez","year":"2019","journal-title":"Oral Oncol."},{"key":"10.1016\/j.bbcan.2026.189647_bb1085","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.canep.2018.12.008","article-title":"Liquid biopsy: miRNA as a potential biomarker in oral cancer","volume":"58","author":"Mazumder","year":"2019","journal-title":"Cancer Epidemiol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb1090","article-title":"Salivary microRNAs for early detection of head and neck squamous cell carcinoma: a case-control study in the high altitude mestizo ecuadorian population","volume":"2018","author":"Salazar-Ruales","year":"2018","journal-title":"Biomed. Res. Int."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb1095","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s12672-025-02510-6","article-title":"Defining the transcriptional routes controlling lncRNA NEAT1 expression: implications in cellular stress response, inflammation, and differentiation","volume":"16","author":"De Domenico","year":"2025","journal-title":"Discov. Oncol."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189647_bb1100","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1038\/s41593-023-01404-6","article-title":"Regional, circuit and network heterogeneity of brain abnormalities in psychiatric disorders","volume":"26","author":"Segal","year":"2023","journal-title":"Nat. Neurosci."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189647_bb1105","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20171070","article-title":"LncRNA DANCR promotes migration and invasion through suppression of lncRNA-LET in gastric cancer cells","volume":"37","author":"Mao","year":"2017","journal-title":"Biosci. Rep."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189647_bb1110","article-title":"Long non-coding RNA UCA1 mediates proliferation and metastasis of laryngeal squamous cell carcinoma cells via regulating miR-185-5p\/HOXA13 axis","volume":"25","author":"Sun","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189647_bb1115","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.ccell.2018.03.006","article-title":"lncRNA epigenetic landscape analysis identifies EPIC1 as an oncogenic lncRNA that interacts with MYC and promotes cell-cycle progression in cancer","volume":"33","author":"Wang","year":"2018","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189647_bb1120","doi-asserted-by":"crossref","first-page":"10495","DOI":"10.1002\/jcb.28334","article-title":"LncRNA UCA1\/miR-124 axis modulates TGF\u03b21-induced epithelial-mesenchymal transition and invasion of tongue cancer cells through JAG1\/Notch signaling","volume":"120","author":"Zhang","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbcan.2026.189647_bb1125","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.656628","article-title":"A super-enhancer driven by FOSL1 controls miR-21-5p expression in head and neck squamous cell carcinoma","volume":"11","author":"Wan","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2026.189647_bb1130","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.biopha.2018.07.005","article-title":"MicroRNA-1469, a p53-responsive microRNA promotes Genistein induced apoptosis by targeting Mcl1 in human laryngeal cancer cells","volume":"106","author":"Ma","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189647_bb1135","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2174\/156800906779010191","article-title":"EGFR-targeting monoclonal antibodies in head and neck cancer","volume":"6","author":"Astsaturov","year":"2006","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.bbcan.2026.189647_bb1140","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0959-8049(01)00233-7","article-title":"The EGFR as a target for anticancer therapy\u2014focus on cetuximab","volume":"37","author":"Baselga","year":"2001","journal-title":"Eur. J. Cancer"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189647_bb1145","article-title":"Cetuximab","volume":"3","author":"Graham","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189647_bb1150","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ccr.2005.03.003","article-title":"Structural basis for inhibition of the epidermal growth factor receptor by cetuximab","volume":"7","author":"Li","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189647_bb1155","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2021.105192","article-title":"Palbociclib and cetuximab compared with placebo and cetuximab in platinum-resistant, cetuximab-na\u00efve, human papillomavirus-unrelated recurrent or metastatic head and neck squamous cell carcinoma: a double-blind, randomized, phase 2 trial","volume":"115","author":"Adkins","year":"2021","journal-title":"Oral Oncol."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189647_bb1160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086697","article-title":"Cetuximab plus platinum-based chemotherapy in head and neck squamous cell carcinoma: a retrospective study in a single comprehensive European cancer institution","volume":"9","author":"De Mello","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189647_bb1165","doi-asserted-by":"crossref","first-page":"e392","DOI":"10.1016\/S2666-7568(24)00048-5","article-title":"Adapted EXTREME regimen in the first-line treatment of fit, older patients with recurrent or metastatic head and neck squamous cell carcinoma (ELAN-FIT): a multicentre, single-arm, phase 2 trial","volume":"5","author":"Guigay","year":"2024","journal-title":"Lancet Healthy Longev."},{"key":"10.1016\/j.bbcan.2026.189647_bb1170","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejca.2021.06.039","article-title":"First-line treatment with chemotherapy plus cetuximab in Chinese patients with recurrent and\/or metastatic squamous cell carcinoma of the head and neck: efficacy and safety results of the randomised, phase III CHANGE-2 trial","volume":"156","author":"Guo","year":"2021","journal-title":"Eur. J. Cancer"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189647_bb1175","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJMoa0802656","article-title":"Platinum-based chemotherapy plus cetuximab in head and neck cancer","volume":"359","author":"Vermorken","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"36","key":"10.1016\/j.bbcan.2026.189647_bb1180","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1200\/JCO.2010.30.6423","article-title":"Induction docetaxel, cisplatin, and cetuximab followed by concurrent radiotherapy, cisplatin, and cetuximab and maintenance cetuximab in patients with locally advanced head and neck cancer","volume":"28","author":"Argiris","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189647_bb1185","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000063809","article-title":"Phase II study with docetaxel and cisplatin in the treatment of recurrent and\/or metastatic squamous cell carcinoma of the head and neck","volume":"63","author":"Gedlicka","year":"2002","journal-title":"Oncology"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189647_bb1190","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1200\/JCO.2002.20.6.1593","article-title":"Phase II trial of docetaxel and cisplatin combination chemotherapy in patients with squamous cell carcinoma of the head and neck","volume":"20","author":"Glisson","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189647_bb1195","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S1470-2045(20)30755-5","volume":"22","author":"Guigay","year":"2021","journal-title":"Lancet Oncol."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189647_bb1200","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1093\/annonc\/mdv268","article-title":"Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II GORTEC study","volume":"26","author":"Guigay","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbcan.2026.189647_bb1205","series-title":"Erlotinib, Profiles of Drug Substances, Excipients and Related Methodology","first-page":"93","author":"Abdelgalil","year":"2020"},{"issue":"10","key":"10.1016\/j.bbcan.2026.189647_bb1210","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1200\/JCO.2003.10.051","article-title":"Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck","volume":"21","author":"Cohen","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb1215","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ygyno.2007.07.057","article-title":"A phase II trial to evaluate gefitinib as second-or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer","volume":"108","author":"Goncalves","year":"2008","journal-title":"Gynecol. Oncol."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189647_bb1220","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1002\/cncr.24265","article-title":"Neoadjuvant chemotherapy\/gefitinib followed by concurrent chemotherapy\/radiation therapy\/gefitinib for patients with locally advanced squamous carcinoma of the head and neck","volume":"115","author":"Hainsworth","year":"2009","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189647_bb1225","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/sj.bjc.6602999","article-title":"Gefitinib (ZD1839, Iressa\u2122) as palliative treatment in recurrent or metastatic head and neck cancer","volume":"94","author":"Kirby","year":"2006","journal-title":"Br. J. Cancer"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189647_bb1230","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.oraloncology.2012.03.020","article-title":"Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck","volume":"48","author":"Perez","year":"2012","journal-title":"Oral Oncol."},{"key":"10.1016\/j.bbcan.2026.189647_bb1235","first-page":"239","article-title":"Gefitinib, profiles of drug substances, excipients and related methodology","volume":"39","author":"Rahman","year":"2014"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189647_bb1240","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1200\/JCO.2008.17.0530","article-title":"Phase III study of gefitinib compared with intravenous methotrexate for recurrent squamous cell carcinoma of the head and neck","volume":"27","author":"Stewart","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189647_bb1245","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/annonc\/mdz388","article-title":"Afatinib versus methotrexate as second-line treatment in Asian patients with recurrent or metastatic squamous cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 3): an open-label, randomised phase III trial","volume":"30","author":"Guo","year":"2019","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189647_bb1250","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/annonc\/mdy013","article-title":"Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN)","volume":"29","author":"Machiels","year":"2018","journal-title":"Ann. Oncol."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189647_bb1255","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1200\/JCO.2012.46.3299","article-title":"Cisplatin and radiotherapy with or without erlotinib in locally advanced squamous cell carcinoma of the head and neck: a randomized phase II trial","volume":"31","author":"Martins","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2026.189647_bb1260","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejca.2022.10.023","article-title":"Afatinib maintenance therapy following post-operative radiochemotherapy in head and neck squamous cell carcinoma: results from the phase III randomised double-blind placebo-controlled study BIB2992ORL (GORTEC 2010\u201302)","volume":"178","author":"Racadot","year":"2023","journal-title":"Eur. J. Cancer"},{"issue":"16","key":"10.1016\/j.bbcan.2026.189647_bb1265","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1200\/JCO.2006.07.6547","article-title":"Phase I\/II trial of erlotinib and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Princess Margaret Hospital phase II consortium and National Cancer Institute of Canada Clinical Trials Group Study","volume":"25","author":"Siu","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb1270","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1200\/JCO.2004.06.075","article-title":"Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck","volume":"22","author":"Soulieres","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2026.189647_bb1275","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-3-319-91442-8_14","article-title":"Afatinib","author":"Wecker","year":"2018","journal-title":"Small Molecul. Oncol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189647_bb1280","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1634\/theoncologist.2017-0661","article-title":"Single arm, phase II study of cisplatin, docetaxel, and erlotinib in patients with recurrent and\/or metastatic head and neck squamous cell carcinomas","volume":"23","author":"William","year":"2018","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb1285","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12885-016-2064-0","article-title":"Cetuximab plus platinum-based chemotherapy in head and neck squamous cell carcinoma: a randomized, double-blind safety study comparing cetuximab produced from two manufacturing processes using the EXTREME study regimen","volume":"16","author":"Soulieres","year":"2016","journal-title":"BMC Cancer"},{"issue":"21","key":"10.1016\/j.bbcan.2026.189647_bb1290","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1200\/JCO.21.02198","article-title":"Pembrolizumab alone or with chemotherapy for recurrent\/metastatic head and neck squamous cell carcinoma in KEYNOTE-048: subgroup analysis by programmed death ligand-1 combined positive score","volume":"40","author":"Burtness","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2026.189647_bb1295","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1360657","article-title":"The clinical outcome of pembrolizumab for patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a single center, real world study in China","volume":"14","author":"Fan","year":"2024","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189647_bb1300","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s41423-025-01310-w","article-title":"NF-\u03baB in inflammation and cancer","volume":"22","author":"Mao","year":"2025","journal-title":"Cell. Mol. Immunol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189647_bb1305","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2174\/157489206778776925","article-title":"Bortezomib in the treatment of cancer","volume":"1","author":"Roccaro","year":"2006","journal-title":"Recent Pat. Anticancer Drug Discov."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189647_bb1310","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3390\/cancers12020265","article-title":"Proteasome inhibitors for the treatment of multiple myeloma","volume":"12","author":"Ito","year":"2020","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189647_bb1315","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrd1159","article-title":"Bortezomib","volume":"2","author":"Paramore","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189647_bb1320","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1093\/annonc\/mdp390","article-title":"Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and\/or metastatic head and neck squamous cell carcinoma","volume":"21","author":"Chung","year":"2010","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189647_bb1325","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/JTO.0b013e31816de276","article-title":"Bortezomib, paclitaxel, and carboplatin as a first-line regimen for patients with metastatic esophageal, gastric, and gastroesophageal cancer: phase II results from the North Central Cancer Treatment Group (N044B)","volume":"3","author":"Jatoi","year":"2008","journal-title":"J. Thorac. Oncol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189647_bb1330","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.ijrobp.2011.09.023","article-title":"Phase I trial using the proteasome inhibitor bortezomib and concurrent chemoradiotherapy for head-and-neck malignancies","volume":"83","author":"Kubicek","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189647_bb1335","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.ccell.2025.07.015","article-title":"Safety and efficacy of a STAT3-targeted cyclic oligonucleotide: from murine models to a phase 1 clinical trial in pet cats with oral cancer","volume":"43","author":"Grandis","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189647_bb1340","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdy287","article-title":"A phase Ib\/II study (SCORES) of durvalumab (D) plus danvatirsen (DAN; AZD9150) or AZD5069 (CX2i) in advanced solid malignancies and recurrent\/metastatic head and neck squamous cell carcinoma (RM-HNSCC): updated results","volume":"29","author":"Cohen","year":"2018","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189647_bb1345","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/7445","article-title":"Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling","volume":"5","author":"Frank","year":"1999","journal-title":"Nat. Med."},{"issue":"18","key":"10.1016\/j.bbcan.2026.189647_bb1350","doi-asserted-by":"crossref","first-page":"26307","DOI":"10.18632\/oncotarget.8368","article-title":"Small-molecule inhibition of STAT3 in radioresistant head and neck squamous cell carcinoma","volume":"7","author":"Bharadwaj","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189647_bb1355","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0167-8140(02)00024-5","article-title":"A phase I study of fludarabine combined with radiotherapy in patients with intermediate to locally advanced head and neck squamous cell carcinoma","volume":"63","author":"Gr\u00e9goire","year":"2002","journal-title":"Radiother. Oncol."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189647_bb1360","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1200\/JCO.1998.16.6.2221","article-title":"Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma","volume":"16","author":"Clayman","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2026.189647_bb1365","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.645745","article-title":"Analysis of adenoviral p53 gene therapy clinical trials in recurrent head and neck squamous cell carcinoma","volume":"11","author":"Sobol","year":"2021","journal-title":"Front. Oncol."},{"issue":"24","key":"10.1016\/j.bbcan.2026.189647_bb1370","doi-asserted-by":"crossref","first-page":"7719","DOI":"10.1158\/1078-0432.CCR-09-1044","article-title":"Biomarkers predict p53 gene therapy efficacy in recurrent squamous cell carcinoma of the head and neck","volume":"15","author":"Nemunaitis","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189647_bb1375","first-page":"798","article-title":"A phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer","volume":"6","author":"Ganly","year":"2000","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189647_bb1380","doi-asserted-by":"crossref","first-page":"709","DOI":"10.4143\/crt.2024.836","article-title":"Clinical impact of TP53 mutations in patients with head and neck cancer who were treated with targeted therapies or immunotherapy","volume":"57","author":"Kang","year":"2025","journal-title":"Cancer Res. Treat."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189647_bb1385","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.3390\/molecules23061479","article-title":"Targeting transcription factors for cancer treatment","volume":"23","author":"Lambert","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bbcan.2026.189647_bb1390","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.795743","article-title":"Drugging fuzzy complexes in transcription","volume":"8","author":"Su","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189647_bb1395","first-page":"7497","article-title":"Application of molecular targeted therapies in the treatment of head and neck squamous cell carcinoma","volume":"15","author":"Kozakiewicz","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbcan.2026.189647_bb1400","series-title":"Annales de Chirurgie Plastique Esth\u00e9tique","first-page":"500","article-title":"Examen anatomopathologique en canc\u00e9rologie mammaire: tour d\u2019horizon des types histologiques, modalit\u00e9s de l\u2019examen, biomarqueurs pr\u00e9dictifs et innovants","author":"Cockenpot","year":"2025"},{"key":"10.1016\/j.bbcan.2026.189647_bb1405","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101426","article-title":"Therapeutic approaches for the treatment of head and neck squamous cell carcinoma \u2013 an update on clinical trials","volume":"21","author":"Goel","year":"2022","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bbcan.2026.189647_bb1410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-021-01080-8","article-title":"Indoleamine 2, 3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy","volume":"14","author":"Tang","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"32","key":"10.1016\/j.bbcan.2026.189647_bb1415","doi-asserted-by":"crossref","first-page":"52345","DOI":"10.18632\/oncotarget.17017","article-title":"Targeting aldehyde dehydrogenase activity in head and neck squamous cell carcinoma with a novel small molecule inhibitor","volume":"8","author":"Kim","year":"2017","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189647_bb1420","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3390\/ph15070830","article-title":"Pentagalloyl glucose and cisplatin combination treatment exhibits a synergistic anticancer effect in 2D and 3D models of head and neck carcinoma","volume":"15","author":"Kantapan","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bbcan.2026.189647_bb1425","doi-asserted-by":"crossref","DOI":"10.1016\/j.mrgentox.2019.503084","article-title":"Combined treatment with cisplatin and the tankyrase inhibitor XAV-939 increases cytotoxicity, abrogates cancer-stem-like cell phenotype and increases chemosensitivity of head-and-neck squamous-cell carcinoma cells","volume":"846","author":"Roy","year":"2019","journal-title":"Mutat. Res. Genet. Toxicol. Environ. Mutagen."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189647_bb1430","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1021\/acsptsci.4c00518","article-title":"Curcumin: a potential weapon in the prevention and treatment of head and neck cancer","volume":"7","author":"Vesel\u00e1","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.bbcan.2026.189647_bb1435","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3332\/ecancer.2015.525","article-title":"Curcumin modulates cellular AP-1, NF-kB, and HPV16 E6 proteins in oral cancer","volume":"9","author":"Mishra","year":"2015","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.bbcan.2026.189647_bb1440","article-title":"Revolutionizing head and neck squamous cell carcinoma treatment with nanomedicine in the era of immunotherapy","volume":"15","author":"Li","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb1445","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1186\/s12951-021-01125-7","article-title":"Gelatinase-sensitive nanoparticles loaded with photosensitizer and STAT3 inhibitor for cancer photothermal therapy and immunotherapy","volume":"19","author":"Bu","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"22","key":"10.1016\/j.bbcan.2026.189647_bb1450","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.160606","article-title":"Small-molecule PROTAC mediates targeted protein degradation to treat STAT3-dependent epithelial cancer","volume":"7","author":"Jin","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbcan.2026.189647_bb1455","doi-asserted-by":"crossref","DOI":"10.3389\/froh.2026.1691816","article-title":"Protacs in oral cancer: degrading oncogenic drivers for next-generation therapy","volume":"7","author":"Prasad","year":"2026","journal-title":"Front. Oral Health"},{"key":"10.1016\/j.bbcan.2026.189647_bb1460","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107613","article-title":"Novel PROTAC probes targeting FOSL1 degradation to eliminate head and neck squamous cell carcinoma cancer stem cells","volume":"151","author":"Zaman","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189647_bb1465","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/ijc.2910610403","article-title":"Human papillomaviruses in 91 oral cancers from Indian betel quid chewers--high prevalence and multiplicity of infections","volume":"61","author":"Balaram","year":"1995","journal-title":"Int. J. Cancer"},{"issue":"36","key":"10.1016\/j.bbcan.2026.189647_bb1470","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.1200\/JCO.2006.07.1829","article-title":"Human papillomavirus and prognosis of oropharyngeal squamous cell carcinoma: implications for clinical research in head and neck cancers","volume":"24","author":"Gillison","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"36","key":"10.1016\/j.bbcan.2026.189647_bb1475","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1200\/JCO.2005.04.6136","article-title":"High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma","volume":"24","author":"Licitra","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189647_bb1480","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djn011","article-title":"Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial","volume":"100","author":"Fakhry","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbcan.2026.189647_bb1485","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3332\/ecancer.2014.475","article-title":"Human papillomavirus detection in head and neck squamous cell carcinoma","volume":"8","author":"Vietia","year":"2014","journal-title":"Ecancermedicalscience"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189647_bb1490","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1002\/hed.28057","article-title":"Circulating tumor HPV-DNA in the management of HPV-positive oropharyngeal carcinoma: a systematic review","volume":"47","author":"Chen","year":"2025","journal-title":"Head Neck"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189647_bb1495","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1158\/1078-0432.CCR-24-3053","article-title":"A prospective trial of biomarker-guided surveillance for HPV-positive oropharynx cancer using plasma tumor tissue\u2013modified viral HPV DNA","volume":"31","author":"Rettig","year":"2025","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189647_bb1500","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1158\/1078-0432.CCR-14-1432","article-title":"HER2 as a therapeutic target in head and neck squamous cell carcinoma","volume":"21","author":"Pollock","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189647_bb1505","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1158\/0008-5472.CAN-17-1672","article-title":"Cross-talk signaling between HER3 and HPV16 E6 and E7 mediates resistance to PI3K inhibitors in head and neck cancer","volume":"78","author":"Brand","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189647_bb1510","article-title":"Current status of human papillomavirus\u2013targeted therapies development in head and neck cancer","volume":"7","author":"Park","year":"2023","journal-title":"JCO Precis Oncol."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189647_bb1515","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004232","article-title":"ISA101 and nivolumab for HPV-16+ cancer: updated clinical efficacy and immune correlates of response","volume":"10","author":"De Sousa","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2026.189647_bb1520","doi-asserted-by":"crossref","first-page":"S628","DOI":"10.1016\/j.annonc.2024.08.940","article-title":"VERSATILE-002: Survival with first-line treatment with PDS0101 therapeutic vaccine and pembrolizumab in HPV16-positive recurrent\/metastatic head and neck squamous cell carcinoma (HNSCC)","volume":"35","author":"Weiss","year":"2024","journal-title":"Ann. Oncol."},{"issue":"30","key":"10.1016\/j.bbcan.2026.189647_bb1525","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1200\/JCO.18.02424","article-title":"T-cell receptor gene therapy for human papillomavirus\u2013associated epithelial cancers: a first-in-human, phase I\/II study","volume":"37","author":"Doran","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189647_bb1530","doi-asserted-by":"crossref","DOI":"10.1172\/JCI188128","article-title":"Immunotherapeutic strategies in head and neck cancer: challenges and opportunities","volume":"135","author":"Liu","year":"2025","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189647_bb1535","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41591-020-01225-1","article-title":"TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers","volume":"27","author":"Nagarsheth","year":"2021","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189647_bb1540","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11912-025-01652-8","article-title":"De-escalation for human papillomavirus-positive oropharyngeal cancer: a look at the prospective evidence","volume":"27","author":"Chen","year":"2025","journal-title":"Curr. Oncol. Rep."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189647_bb1545","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/joim.20088","article-title":"Therapeutic options for human papillomavirus-positive tonsil and base of tongue cancer","volume":"297","author":"Zupancic","year":"2025","journal-title":"J. Intern. Med."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189647_bb1550","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/abbs\/gmx078","article-title":"Exosomes containing miR-21 transfer the characteristic of cisplatin resistance by targeting PTEN and PDCD4 in oral squamous cell carcinoma","volume":"49","author":"Liu","year":"2017","journal-title":"Acta Biochim. Biophys. Sin."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189647_bb1555","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109929","article-title":"Activation of miR-21 by STAT3 induces proliferation and suppresses apoptosis in nasopharyngeal carcinoma by targeting PTEN gene","volume":"9","author":"Ou","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189647_bb1560","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213463","article-title":"TNF-\u03b1-induced miR-450a mediates TMEM182 expression to promote oral squamous cell carcinoma motility","volume":"14","author":"Hsing","year":"2019","journal-title":"PLoS One"},{"issue":"24","key":"10.1016\/j.bbcan.2026.189647_bb1565","doi-asserted-by":"crossref","first-page":"7539","DOI":"10.1158\/1078-0432.CCR-11-2102","article-title":"Significance of dysregulated metadherin and microRNA-375 in head and neck cancer","volume":"17","author":"Hui","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189647_bb1570","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3390\/cancers10080272","article-title":"miR-1246 targets CCNG2 to enhance cancer stemness and chemoresistance in oral carcinomas","volume":"10","author":"Lin","year":"2018","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189647_bb1575","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1002\/ijc.31638","article-title":"miR-134 targets PDCD7 to reduce E-cadherin expression and enhance oral cancer progression","volume":"143","author":"Peng","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189647_bb1580","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/jhg.2011.66","article-title":"Tumor suppressive microRNA-375 regulates oncogene AEG-1\/MTDH in head and neck squamous cell carcinoma (HNSCC)","volume":"56","author":"Nohata","year":"2011","journal-title":"J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189647_bb1585","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41419-023-05667-6","article-title":"LncRNA MALAT1 promotes growth and metastasis of head and neck squamous cell carcinoma by repressing VHL through a non-canonical function of EZH2","volume":"14","author":"Duan","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2026.189647_bb1590","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.2147\/OTT.S192069","article-title":"lncRNA MALAT1 potentiates the progression of tongue squamous cell carcinoma through regulating miR-140-5p-PAK1 pathway","author":"Zhu","year":"2019","journal-title":"Onco. Targets Ther."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189647_bb1595","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/cas.12092","article-title":"Long non-coding RNA HOTAIR is an independent prognostic marker for nasopharyngeal carcinoma progression and survival","volume":"104","author":"Nie","year":"2013","journal-title":"Cancer Sci."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189647_bb1600","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.3892\/ijo.2015.2976","article-title":"Long non-coding RNA HOTAIR promotes tumor cell invasion and metastasis by recruiting EZH2 and repressing E-cadherin in oral squamous cell carcinoma","volume":"46","author":"Wu","year":"2015","journal-title":"Int. J. Oncol."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189647_bb1605","first-page":"720","article-title":"Downregulation of lncRNA HOTTIP suppresses the proliferation, migration, and invasion of oral tongue squamous cell carcinoma by regulation of HMGA2-mediated Wnt\/\u03b2-catenin pathway","volume":"35","author":"Xiong","year":"2020","journal-title":"Cancer Biother. Radiopharm."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189647_bb1610","doi-asserted-by":"crossref","first-page":"8805","DOI":"10.1007\/s13277-015-3645-2","article-title":"Long non-coding RNA HOTTIP is correlated with progression and prognosis in tongue squamous cell carcinoma","volume":"36","author":"Zhang","year":"2015","journal-title":"Tumour Biol."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189647_bb1615","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/cas.13058","article-title":"Long non-coding RNA UCA 1 contributes to the progression of oral squamous cell carcinoma by regulating the WNT\/\u03b2-catenin signaling pathway","volume":"107","author":"Yang","year":"2016","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbcan.2026.189647_bb1620","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2020.104941","article-title":"miR-223 regulates oral squamous cell carcinoma metastasis through the Wnt\/\u03b2-catenin signaling pathway","volume":"109","author":"Wei","year":"2020","journal-title":"Oral Oncol."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189647_bb1625","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.3390\/cells8111455","article-title":"miRNA-29b inhibits prostate tumor growth and induces apoptosis by increasing bim expression","volume":"8","author":"Sur","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bbcan.2026.189647_bb1630","doi-asserted-by":"crossref","DOI":"10.4143\/crt.2025.482","article-title":"Chemoradiotherapy increases the incidence rate of cachexia in head and neck cancer: a cohort study","author":"Lin","year":"2025","journal-title":"Cancer Res. Treat."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189647_bb1635","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/2211-5463.70042","article-title":"Long non-coding RNAs as therapeutic targets in head and neck squamous cell carcinoma and clinical application","volume":"15","author":"Tran","year":"2025","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.bbcan.2026.189647_bb1640","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.101990","article-title":"PiR-hsa-23533 promotes malignancy in head and neck squamous cell carcinoma via USP7","volume":"45","author":"Hu","year":"2024","journal-title":"Transl. Oncol."},{"issue":"57","key":"10.1016\/j.bbcan.2026.189647_bb1645","doi-asserted-by":"crossref","first-page":"33222","DOI":"10.1039\/C9RA06133A","article-title":"NCPCDA: network consistency projection for circRNA\u2013disease association prediction","volume":"9","author":"Li","year":"2019","journal-title":"RSC Adv."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189647_bb1650","doi-asserted-by":"crossref","DOI":"10.3390\/cancers8040041","article-title":"HPV positive head and neck cancers: molecular pathogenesis and evolving treatment strategies","volume":"8","author":"Dok","year":"2016","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189647_bb1655","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/qjmed\/hcp176","article-title":"Human papillomavirus-associated oropharyngeal cancer: a new clinical entity","volume":"103","author":"Nguyen","year":"2009","journal-title":"QJM"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189647_bb1660","first-page":"299","article-title":"HPV in oropharyngeal cancer: the basics to know in clinical practice","volume":"34","author":"Elrefaey","year":"2015","journal-title":"Acta Otorhinolaryngol. Ital."},{"issue":"Suppl. 1","key":"10.1016\/j.bbcan.2026.189647_bb1665","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1007\/s12105-012-0377-0","article-title":"Epidemiology and clinical aspects of HPV in head and neck cancers","volume":"6","author":"Chaturvedi","year":"2012","journal-title":"Head Neck Pathol."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189647_bb1670","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/hed.20796","article-title":"Cystic lymph node metastasis in patients with head and neck cancer: an HPV-associated phenomenon","volume":"30","author":"Goldenberg","year":"2008","journal-title":"Head Neck"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb1675","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123443","article-title":"Mutational analysis of head and neck squamous cell carcinoma stratified by smoking status","volume":"4","author":"Ghasemi","year":"2019","journal-title":"JCI Insight"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189647_bb1680","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1158\/2159-8290.CD-12-0537","article-title":"Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers","volume":"3","author":"Pickering","year":"2013","journal-title":"Cancer Discov."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189647_bb1685","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1200\/JCO.2008.20.2853","article-title":"Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck","volume":"27","author":"Lassen","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2026.189647_bb1690","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.699044","article-title":"Phytochemicals as potential chemopreventive and chemotherapeutic agents for emerging human papillomavirus\u2013driven head and neck cancer: current evidence and future prospects","volume":"12","author":"Aggarwal","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb1695","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41199-016-0003-z","article-title":"Genomic insights into head and neck cancer","volume":"1","author":"Beck","year":"2016","journal-title":"Cancers Head Neck"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189647_bb1700","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/ng.2935","article-title":"Genomic and molecular characterization of esophageal squamous cell carcinoma","volume":"46","author":"Lin","year":"2014","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189647_bb1705","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1158\/1078-0432.CCR-13-3310","article-title":"Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas","volume":"21","author":"Seiwert","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189647_bb1710","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1042\/BJ20112017","article-title":"Virology and molecular pathogenesis of HPV (human papillomavirus)-associated oropharyngeal squamous cell carcinoma","volume":"443","author":"Miller","year":"2012","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb1715","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/gr.241141.118","article-title":"Human papillomavirus and the landscape of secondary genetic alterations in oral cancers","volume":"29","author":"Gillison","year":"2019","journal-title":"Genome Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189647_bb1720","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1038\/s41598-018-20086-w","article-title":"SOX2 activation predicts prognosis in patients with head and neck squamous cell carcinoma","volume":"8","author":"Chung","year":"2018","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189647_bb1725","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1002\/ijc.32412","article-title":"Identification of prognostic molecular biomarkers in 157 HPV-positive and HPV-negative squamous cell carcinomas of the oropharynx","volume":"145","author":"Dogan","year":"2019","journal-title":"Int. J. Cancer"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189647_bb1730","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1093\/carcin\/bgu094","article-title":"Expression and role of the embryonic protein SOX2 in head and neck squamous cell carcinoma","volume":"35","author":"Schr\u00f6ck","year":"2014","journal-title":"Carcinogenesis"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189647_bb1735","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1470-2045(15)70124-5","article-title":"Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial","volume":"16","author":"Machiels","year":"2015","journal-title":"Lancet Oncol."},{"issue":"10212","key":"10.1016\/j.bbcan.2026.189647_bb1740","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(19)32591-7","article-title":"Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study","volume":"394","author":"Burtness","year":"2019","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189647_bb1745","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/annonc\/mdv196","article-title":"Phase I dose-escalating trial of Escherichia coli purine nucleoside phosphorylase and fludarabine gene therapy for advanced solid tumors","volume":"26","author":"Rosenthal","year":"2015","journal-title":"Ann. Oncol."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189647_bb1750","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/78638","article-title":"A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer","volume":"6","author":"Khuri","year":"2000","journal-title":"Nat. Med."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26001198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26001198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:08:08Z","timestamp":1794564488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X26001198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":350,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0304419X26001198"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189647","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting transcriptional and post-transcriptional pathways in head and neck cancer","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189647","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"189647"}}